New drug HCB301 takes on tough cancers in early human trial
NCT ID NCT06487624
First seen Feb 05, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This early-phase study tests an investigational drug called HCB301 in adults with advanced solid tumors or classical Hodgkin lymphoma that has come back or not responded to other treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 50 participants will receive the drug by IV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITINGKaohsiung City, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prisma Health-Upstate
RECRUITINGGreenville, South Carolina, 29605, United States
-
Southern Medical University Zhujiang Hospital
RECRUITINGZhujiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xuzhou Central Hospital
RECRUITINGXuzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yantai Yuhuangding Hospital
RECRUITINGYantai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhejiang Provincial Cancer Hospital
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.